The studies behind Dream Peptides.
For people exploring sleep, peptides and aging who want to understand what an experiment actually found.
How a study is assessed
Dream Peptides brings together studies of epitalon, telomeres, MOTS-c and NAD+. The subjects overlap in discussions of longevity, but they do not form a single treatment approach. Each needs its own account of what was tested and what remains unknown.
The starting point is the material itself. Epitalon is a defined synthetic peptide; epithalamin is an extract. NAD+ is a coenzyme; NMN and NR are precursors cells can use to make it. A result for one of these materials cannot simply be assigned to another.
The next questions concern the study setting and the outcome. Cells grown outside the body, animal experiments, observational human studies and randomized trials offer different kinds of evidence. The pages make those differences visible beside the finding, where they affect its meaning.
Why sleep is part of the subject
The rat pineal-cell experiment gives epitalon’s sleep reputation a concrete scientific starting point. Researchers measured changes in the machinery that makes melatonin and in the amount released into culture medium. That is a specific finding about a night-related hormone signal.
It leaves a different question unanswered: whether a person sleeps better. The site keeps that distinction in view because a hormone measurement can sound like a complete sleep result when summarized too broadly. The epitalon page follows the experiment and its limits in more detail.
MOTS-c and NAD+ widen the subject to movement and cellular energy. They belong here because they appear in many of the same longevity discussions, while offering different study designs and outcomes. Their presence does not establish that the compounds work together or treat the same problem.
Benefits and limits belong together
A promising finding can be described accurately without becoming a recommendation. Mouse running tests, a change in muscle insulin sensitivity and a rise in blood NAD+ are each worth understanding in their own terms. None can establish every benefit implied by the word “longevity.”
The pages also include findings that complicate the hopeful account. The 2025 epitalon cell study found longer telomeres in breast-cancer cells as well as normal cells. The human NAD+ review describes uneven clinical benefits despite frequent increases in blood markers.
Safety is considered separately from efficacy. A study that detects a change does not automatically establish that the change is desirable, or that the tested material is safe over time. Missing safety data remain a gap even when no harm was reported in a small experiment.
How sources appear here
Links in the text lead to the study or review supporting the nearby claim. The references page collects those records and describes their setting and purpose. A review provides context across studies; an original paper provides the details of a particular experiment.
Study duration, the population tested and unchanged outcomes all matter to interpretation. Short trials are described as short trials. An association between a naturally occurring marker and an outcome is kept separate from the effect of administering a compound.
Anecdotal experiences are labeled as such. They can describe what people report without establishing a cause, an effective schedule or a safety profile. Accounts of no effect also belong in the picture. No personal treatment instructions follow from those reports.
The role of these pages
The site is for understanding published work, including the questions it cannot answer. It does not diagnose symptoms, select treatments or assess whether any compound is appropriate for an individual. Dream Peptides sells no products, writes no prescriptions and treats no one.
Medical decisions require personal care that can account for symptoms, health history and current treatment. A page about a study cannot provide that assessment. The contact page explains how to raise a factual correction while keeping personal medical details out of the discussion.
The aim is a careful account that stays close to the experiment. The most useful next step may be a better trial, a safety study or a more precise question. Uncertainty is part of the subject, and the wording is intended to preserve it rather than hide it.